5 thoughts on navigating healthcare's future landscape

With more healthcare companies expanding and others combining to form technological powerhouses, the healthcare landscape is drastically changing. The question that healthcare leaders ask now becomes “how do we navigate through this unknown territory?”

“The reasons systems alter their strategic direction vary, but many do so to address challenges in their market,” writes Ayla Ellison of Becker’s Hospital Review. “From the physician shortage to ensuring a system has enough marketshare to stay competitive, there are a plethora of issues for healthcare leaders to consider.”

Read more by following the link below:

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.